This guide explains how the treatment works, what it helps with, and what to expect when you come in
The following timeframes are supported by clinical trial data and prescribing information: Nausea: Most commonly peaks in the first one to two weeks at each dose level, then improves significantly over weeks three to four
Upon acid-triggered lattice dissolution, the peptide is released while transiently buffering the intravesicular pH [180]
Reconstitution volume should be determined by dosing precision needs rather than storage considerations, as storage stability is limited to 28 days at 28C regardless of concentration
(CDC) Problem solution: When symptoms suggest IBD (blood, nighttime diarrhea, weight loss, ongoing cramping), we move quickly with labs and stool inflammation markers, then coordinate GI referral for scope-based diagnosis